Stock Titan Trading tools for traders and investors.

-

09:20:04 AM

Last BNTX Stock Market News

BNTX - BioNTech SE

12/23/20 7:00 AM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies' COVID-19 Vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to

RHEA-AI

neutral

12/21/20 2:10 PM

Nasdaq : BNTX

BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program

Mainz, Germany, December 21, 2020 - BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") will hold a press conference including a video webcast on Tuesday, December 22, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine

RHEA-AI

neutral

12/21/20 2:09 PM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY (R) (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus,

RHEA-AI

very positive

12/21/20 2:05 PM

Nasdaq : BNTX

Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine

COMIRNATY (R) (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine Pfizer and BioNTech are ready to immediately ship initial doses to the 27 EU member states

RHEA-AI

very positive

12/21/20 9:21 AM

NYSE, Nasdaq : PFE, BNTX

Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion to recommend the conditional marketing authorization (CMA) of the Pfizer-BioNTech COVID-19 Vaccine

RHEA-AI

negative

12/21/20 9:17 AM

Nasdaq : BNTX

Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine

European Commission decision on conditional marketing authorization expected imminently Positive CHMP opinion follows several emergency use authorizations worldwide; committee reviewed totality of scientific evidence, including Phase 3 efficacy and safety data If authorized, BNT162b2 will be the

RHEA-AI

negative

12/16/20 3:00 AM

Nasdaq : BNTX

BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine

Supply agreement reflects both companies' shared commitment and efforts to achieve vaccine accessibility and affordability in China A local Phase 2 clinical trial of mRNA COVID-19 vaccine candidate BNT162b2 is on-going in Jiangsu, China MAINZ, GERMANY, and SHANGHAI, CHINA, December 16, 2020 (GLOBE

RHEA-AI

positive

12/14/20 6:00 AM

Nasdaq : BNTX

Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2

Analysis of 37 participants immunized with BNT162b2 showed a broad immune response with SARS-CoV-2-specific neutralizing antibodies, T H 1 type CD4+ T cells, and strong expansion of CD8+ T cells of the early effector memory phenotype All vaccinated participants demonstrated neutralizing antibody as

RHEA-AI

neutral

12/11/20 11:15 PM

Nasdaq : BNTX

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately Pfizer and BioNTech previously announced an agreement with the U.S. Government to supply doses in 2020 & 2021 In collaboration with Operation Warp Speed, Pfizer and

RHEA-AI

neutral

12/10/20 6:50 PM

Nasdaq : BNTX

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.

FDA expected to make a decision on Emergency Use Authorization in the coming days Positive vote based on totality of scientific evidence presented by the companies, including Phase 3 efficacy and safety data If authorized, BNT162b2 would be the first COVID-19 vaccine available in the U.S. NEW YORK

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 Next